{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:37:52Z","timestamp":1780051072545,"version":"3.53.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s12325-022-02055-y","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T13:04:19Z","timestamp":1646312659000},"page":"1871-1880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Surviving Benzodiazepines: A Patient\u2019s and Clinician\u2019s Perspectives"],"prefix":"10.1007","volume":"39","author":[{"given":"Carrie M.","family":"Silvernail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5448-6929","authenticated-orcid":false,"given":"Steven L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"2055_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF00429621","volume":"2","author":"LE Hollister","year":"1961","unstructured":"Hollister LE, Motzenbecker FP, Degan RO. Withdrawal reactions from chlordiazepoxide (\u201cLibrium\"). Psychopharmacologia. 1961;2:63\u20138.","journal-title":"Psychopharmacologia"},{"issue":"10","key":"2055_CR2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/archpsyc.1990.01810220015002","volume":"47","author":"K Rickels","year":"1990","unstructured":"Rickels K, Schweizer E, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry. 1990;47(10):899\u2013907.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"2055_CR3","first-page":"147","volume":"20","author":"A Pelissolo","year":"1994","unstructured":"Pelissolo A, Bisserbe JC. Dependence on benzodiazepines. Clinical and biological aspects. Encephale. 1994;20(2):147\u201357.","journal-title":"Encephale"},{"issue":"1","key":"2055_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11920-015-0642-5","volume":"18","author":"M Lader","year":"2016","unstructured":"Lader M, Kyriacou A. Withdrawing benzodiazepines in patients with anxiety disorders. Curr Psychiatry Rep. 2016;18(1):8.","journal-title":"Curr Psychiatry Rep"},{"issue":"8339","key":"2055_CR5","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/S0140-6736(83)92355-3","volume":"1","author":"P Tyrer","year":"1983","unstructured":"Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet. 1983;1(8339):1402\u20136.","journal-title":"Lancet"},{"key":"2055_CR6","unstructured":"Ashton H. The Ashton manual: benzodiazepines\u2014how they work and how to withdraw. 2002"},{"issue":"2","key":"2055_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/bcp.12148","volume":"77","author":"F Lugoboni","year":"2014","unstructured":"Lugoboni F, Quaglio G. Exploring the dark side of the moon: the treatment of benzodiazepine tolerance. Br J Clin Pharmacol. 2014;77(2):239\u201341.","journal-title":"Br J Clin Pharmacol"},{"key":"2055_CR8","unstructured":"Wright. Benzodiazepine withdrawal: clinical aspects. In: Peppin J, Raffa R, Pergolizzi J, Wright S, editors. The benzodiazepines crisis:\u00a0the ramifications of an overused drug class. New York: Oxford University Press; 2020."},{"key":"2055_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/02791072.1983.10472127","volume":"15","author":"DE Smith","year":"1983","unstructured":"Smith DE, Wesson DR. Benzodiazepine dependency syndromes. J Psychoactive Drugs. 1983;15:85\u201395.","journal-title":"J Psychoactive Drugs"},{"issue":"11","key":"2055_CR10","first-page":"1093","volume":"127","author":"CS Mellor","year":"1982","unstructured":"Mellor CS, Jain VK. Diazepam withdrawal syndrome: its prolonged and changing nature. Can Med Assoc J. 1982;127(11):1093\u20136.","journal-title":"Can Med Assoc J"},{"issue":"13","key":"2055_CR11","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1177\/1049732317728053","volume":"27","author":"AM Fixsen","year":"2017","unstructured":"Fixsen AM, Ridge D. Stories of hell and healing: internet users\u2019 construction of benzodiazepine distress and withdrawal. Qual Health Res. 2017;27(13):2030\u201341.","journal-title":"Qual Health Res"},{"issue":"Suppl","key":"2055_CR12","first-page":"29","volume":"48","author":"MJ Mills","year":"1987","unstructured":"Mills MJ, Eth S. Consent and liability: special problems with anxiolytics. J Clin Psychiatry. 1987;48(Suppl):29\u201332.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"2055_CR13","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2147\/NDT.S1224","volume":"4","author":"CB Pull","year":"2008","unstructured":"Pull CB, Damsa C. Pharmacotherapy of panic disorder. Neuropsychiatr Dis Treat. 2008;4(4):779\u201395.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2055_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2296-13-40","volume":"13","author":"MD Mitchell","year":"2012","unstructured":"Mitchell MD, Gehrman P, Perlis M, et al. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012;13:40.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"2055_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamapsychiatry.2019.3986","volume":"77","author":"EAM van Dis","year":"2020","unstructured":"van Dis EAM, van Veen SC, Hagenaars MA, et al. Long-term outcomes of cognitive behavioral therapy for anxiety-related disorders. A systematic review and meta-analysis. JAMA Psychiat. 2020;77(3):265\u201373.","journal-title":"JAMA Psychiat"},{"key":"2055_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.smrv.2014.11.007","volume":"23","author":"JM Geiger-Brown","year":"2015","unstructured":"Geiger-Brown JM, Rogers VE, Liu W, et al. Cognitive behavioral therapy in persons with comorbid insomnia: a meta-analysis. Sleep Med Rev. 2015;23:54\u201367.","journal-title":"Sleep Med Rev"},{"issue":"5","key":"2055_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1177\/0269881118822146","volume":"33","author":"C Gale","year":"2019","unstructured":"Gale C, Glue P, Guaiana G, et al. Influence of covariates on heterogeneity in Hamilton Anxiety Scale ratings in placebo-controlled trials of benzodiazepines in generalized anxiety disorder: systematic review and meta-analysis. J Psychopharmacol. 2019;33(5):543\u20137.","journal-title":"J Psychopharmacol"},{"issue":"7","key":"2055_CR18","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/0278-5846(94)90118-X","volume":"18","author":"GA Fava","year":"1994","unstructured":"Fava GA, Grandi S, Belluardo P, et al. Benzodiazepines and anxiety sensitivity in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18(7):1163\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"2055_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0013-7006(07)91556-0","volume":"33","author":"A P\u00e9lissolo","year":"2007","unstructured":"P\u00e9lissolo A, Maniere F, Boutges B, et al. Anxiety and depressive disorders in 4,425 long term benzodiazepine users in general practice. Encephale. 2007;33(1):32\u20138.","journal-title":"Encephale"},{"key":"2055_CR20","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/bmj.288.6424.1135","volume":"288","author":"H Ashton","year":"1984","unstructured":"Ashton H. Benzodiazepine withdrawal: an unfinished story. Br Med J. 1984;288:1135\u201340.","journal-title":"Br Med J"},{"issue":"2","key":"2055_CR21","doi-asserted-by":"publisher","first-page":"22746","DOI":"10.4088\/PCC.16r02037","volume":"19","author":"TJ Dodds","year":"2017","unstructured":"Dodds TJ. Prescribed benzodiazepines and suicide risk: a review of the literature. Prim Care Companion CNS Disord. 2017;19(2):22746.","journal-title":"Prim Care Companion CNS Disord."},{"issue":"10","key":"2055_CR22","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.3390\/ijerph8104025","volume":"8","author":"S Sussman","year":"2011","unstructured":"Sussman S, Sussman AI. Considering the definition of addiction. Int J Environ Res Public Health. 2011;8(10):4025\u201338.","journal-title":"Int J Environ Res Public Health"},{"issue":"2\u20133","key":"2055_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.drugalcdep.2007.04.009","volume":"90","author":"WC Becker","year":"2007","unstructured":"Becker WC, Fiellin DA, Desai RA. Non-medical use, abuse and dependence on sedatives and tranquilizers among US adults: psychiatric and socio-demographic correlates. Drug Alcohol Depend. 2007;90(2\u20133):280\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"2055_CR24","first-page":"321","volume":"83","author":"S Borg","year":"1986","unstructured":"Borg S, Blennow G, Sandberg P, et al. Benzodiazepine dependence and other long-term adverse effects - a review. Lakartidningen. 1986;83(5):321\u20133, 326.","journal-title":"Lakartidningen"},{"issue":"11","key":"2055_CR25","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1360-0443.1994.tb03743.x","volume":"89","author":"H P\u00e9tursson","year":"1994","unstructured":"P\u00e9tursson H. The benzodiazepine withdrawal syndrome. Addiction. 1994;89(11):1455\u20139.","journal-title":"Addiction"},{"key":"2055_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mehy.2018.06.019","volume":"118","author":"S LaCorte","year":"2018","unstructured":"LaCorte S. How chronic administration of benzodiazepines leads to unexplained chronic illnesses: a hypothesis. Med Hypotheses. 2018;118:59\u201367.","journal-title":"Med Hypotheses"},{"key":"2055_CR27","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Substance-related and addictive disorders. In: Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington: American Psychiatric Association; 2013. p. 481\u2013490, 550\u2013560.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"Suppl","key":"2055_CR28","first-page":"22","volume":"48","author":"JB Herman","year":"1987","unstructured":"Herman JB, Brotman AW, Rosenbaum JF. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines. J Clin Psychiatry. 1987;48(Suppl):22\u20138.","journal-title":"J Clin Psychiatry"},{"key":"2055_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.euroneuro.2021.10.001","volume":"55","author":"MA Horowitz","year":"2022","unstructured":"Horowitz MA, Taylor D. How to reduce and stop psychiatric medication. Eur Neuropsychopharmacol. 2022;55:4\u20137.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"2055_CR30","first-page":"1015","volume":"169","author":"L Baillargeon","year":"2003","unstructured":"Baillargeon L, Landreville P, Verreault R, et al. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioral therapy combined with gradual tapering: a randomized trial. CMAJ. 2003;169(10):1015\u201320.","journal-title":"CMAJ"},{"key":"2055_CR31","first-page":"CD011481","volume":"3","author":"L Baandrup","year":"2018","unstructured":"Baandrup L, Ebdrup BH, Rasmussen J\u00d8, et al. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users. Cochrane Database Syst Rev. 2018;3:CD011481.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2055_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1017\/S2045796016000032","volume":"25","author":"G Guaiana","year":"2016","unstructured":"Guaiana G, Barbui C. Discontinuing benzodiazepines: best practices. Epidemiol Psychiatr Sci. 2016;25(3):214\u20136.","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"1","key":"2055_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/0023210-200923010-00002","volume":"23","author":"M Lader","year":"2009","unstructured":"Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs. 2009;23(1):19\u201334.","journal-title":"CNS Drugs"},{"key":"2055_CR34","doi-asserted-by":"publisher","first-page":"204512532096718","DOI":"10.1177\/2045125320967183","volume":"10","author":"A Guy","year":"2020","unstructured":"Guy A, Brown M, Lewis S, Horowitz M. The \u201cpatient voice\u201d: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition. Ther Adv Psychopharmacol. 2020;10:2045125320967183.","journal-title":"Ther Adv Psychopharmacol"},{"key":"2055_CR35","unstructured":"Pittman CM, Youngs W, Karle E. Social networking and benzodiazepine withdrawal: the realities of dependence and the necessity of support. In: Presented at the 33rd annual national conference of the anxiety and depression association of America, La Jolla, April 2013. https:\/\/adaa.org\/sites\/default\/files\/Pittman121.pdf."},{"key":"2055_CR36","unstructured":"Young A. Survey of benzodiazepine withdrawal outcomes of an internet benzodiazepine group. 2007. www.benzosupport.org\/survey_contents.htm."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02055-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T07:15:22Z","timestamp":1651302922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02055-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2055"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02055-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]},"assertion":[{"value":"15 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}